MRK Options Setup: Bullish OI at $140 Calls Signals Upside Potential Amid Earnings Watch

• Merck (MRK) trades at $128.52, holding firm above key moving averages despite a slight intraday dip.
• Heavy Open Interest in $140 Calls for next Friday suggests market participants are positioning for a significant breakout.
• Q2 earnings loom on Tuesday, with revenue expected at $16.33 billion and strong Keytruda sales in focus.
• Technical indicators point to a constructive uptrend, with RSI at 62.96 indicating room for growth without being overbought.

Merck is standing at a crossroads, but the path forward looks surprisingly clear if you know where to look. The stock is currently hovering around $128.52, having pulled back slightly from its previous close of $130.20. It’s easy to get distracted by the red ink on the daily change, but the bigger picture tells a different story. The options market is whispering, then shouting, that investors are betting on a move higher. With earnings just days away, the setup isn't just about hope; it's about calculated positioning. The data suggests that while there is some near-term hesitation, the dominant sentiment leans firmly toward upside potential.

The Options Market Speaks: $140 Calls Lead the Charge

When you dig into the options chain, the story becomes compelling. The most striking feature is the massive Open Interest (OI) in the $140 Call options expiring next Friday, MRK20260814C140, with an OI of 1,099 contracts. This is significantly higher than any other strike. For context, the next highest call OI is at $132 with 439 contracts. This disparity isn't random. It indicates that smart money is positioning for a breakout above the current resistance levels, targeting a move toward $140.

On the downside, the Put side is less dramatic. The highest Put OI is at $116 with 805 contracts for this Friday, followed by $124 with 489. The Put/Call ratio for Open Interest is 0.8157, which is below 1.0. This is a bullish signal. It means there are more calls than puts outstanding, suggesting that the market is more eager to bet on gains than to hedge against losses.

There’s also a notable concentration of calls at $132 for both this Friday (MRK20260807C132, OI: 609) and next Friday. This suggests that $132 is a key psychological and technical resistance level that traders are trying to break through. The absence of significant whale block trades today means this move is being driven by a broader consensus rather than a single institutional player, which can sometimes be more stable. However, the heavy OI at $140 acts as a magnet. If the stock breaks above $132 with volume, the gamma exposure from those $140 calls could accelerate the price movement upward.

Earnings Expectations Fuel the Narrative

The fundamentals are aligning with the technicals. Merck is set to report Q2 earnings this Tuesday, with analysts expecting revenue of $16.33 billion. This represents a 3.3% year-over-year growth, driven largely by Keytruda sales, which are projected to hit $8.06 billion. The market is also watching the launch of Winrevair and the potential rebound in Gardasil volumes in China.

While the consensus EPS is a loss of $0.26 due to heavy R&D charges from acquisitions like Cidara Therapeutics and Terns Pharmaceuticals, the revenue beat is what matters for the stock price. Last quarter, Merck beat revenue expectations, and history suggests they rarely miss. The news flow is supportive, with analysts reconfirming their estimates. The average analyst price target is $135.19, which is about 5% above the current price. This fundamental backdrop provides a safety net for the bullish options positioning. If earnings exceed expectations, the $140 call options could see a significant surge in value.

Actionable Trading Opportunities

So, how do you play this? The trend is up, but the stock is testing resistance. Here’s how to structure your trade:

• Stock Entry: Consider entering a long position in MRK stock near $128.50 if it holds above the 30-day moving average of $126.10. A tighter entry could be near $130.00 if it reclaims that level, with a stop-loss below $126.00. The target is the next resistance at $135.00, with a stretch to $140.00.
• Options Strategy: For a bullish play, the MRK20260814C140 call is the most attractive. It offers a good balance of leverage and time value. If you’re more conservative, the MRK20260807C132 call could benefit from a quick breakout this week. Avoid the $116 puts unless you expect a sharp reversal, as the odds are currently stacked against a drop.
• Risk Management: The key risk is a failure to break above $132. If the stock drops below $127.32 (the middle Bollinger Band), the bullish thesis weakens. In that case, consider exiting or hedging with puts.

Volatility on the Horizon

Merck is in a strong position, but the next few days will be critical. The options market is clearly betting on a move higher, with $140 as the ultimate target. The earnings report will be the catalyst, but the technical setup is already in place. If the stock can hold above $130 and break through $132, the path to $140 could be surprisingly smooth. Keep an eye on volume, as it needs to confirm the move. For now, the trend is your friend, and the options data is pointing the way.